Eisai Inc.

URI: https://gptkb.org/entity/Eisai_Inc.

GPTKB entity

Predicate	Object
gptkbp:instance_of	gptkb:pharmaceuticals
gptkbp:acquisition	gptkb:Medi_Gene_AG
gptkbp:acquisition_year	gptkb:2018
gptkbp:ceo	gptkb:Haruo_Naito
gptkbp:clinical_trial	ongoing
gptkbp:collaboration	gptkb:University_of_Tokyo
gptkbp:employees	over 10,000
gptkbp:founded	1941
gptkbp:founder	gptkb:Toichi_Hoshino
gptkbp:global_presence	over 70 countries
gptkbp:headquarters	gptkb:Tokyo gptkb:Tokyo,_Japan
https://www.w3.org/2000/01/rdf-schema#label	Eisai Inc.
gptkbp:industry	gptkb:pharmaceuticals
gptkbp:market	global
gptkbp:partnership	gptkb:Incyte_Corporation gptkb:GSK gptkb:Johnson_&_Johnson gptkb:Zymeworks gptkb:Takeda_Pharmaceutical_Company gptkb:Aclaris_Therapeutics gptkb:Astra_Zeneca gptkb:Sanofi gptkb:Boehringer_Ingelheim gptkb:Bristol-Myers_Squibb gptkb:Pfizer gptkb:Regeneron_Pharmaceuticals gptkb:Merck_&_Co. gptkb:Roche gptkb:Mirati_Therapeutics gptkb:Amgen gptkb:Blueprint_Medicines gptkb:Eli_Lilly_and_Company gptkb:Vertex_Pharmaceuticals gptkb:Abb_Vie gptkb:Celgene gptkb:Sarepta_Therapeutics gptkb:Novartis gptkb:Nant_Kwest
gptkbp:philanthropy	Eisai Co., Ltd. Foundation
gptkbp:product_line	anti-cancer drugs Alzheimer's disease treatments
gptkbp:products	medications
gptkbp:research_and_development	high investment
gptkbp:research_areas	neurology oncology
gptkbp:research_focus	neurology
gptkbp:revenue	$4.5 billion (2020)
gptkbp:stock_exchange	gptkb:Tokyo_Stock_Exchange
gptkbp:stock_symbol	4523
gptkbp:subsidiary	gptkb:Eisai_Co.,_Ltd.
gptkbp:website	www.eisai.com
gptkbp:bfsParent	gptkb:Eisai
gptkbp:bfsLayer	5